Tyrosine hydroxylase (TH) is the rate-limiting enzyme in dopamine (DA) biosynthesis.
Following amplification of the DNA fragment from 201 Japanese schizophrenic patients and 67 Japanese control subjects, allelic variations of the fragment containing exon 3 of the TH gene were analyzed by direct sequencing. No allelic anomalies were detected in any of the individuals sequenced. (The occurrence of the G to A transition changing the amino acid Val81 to Met81 is described in the paragraph below.) It should be emphasized that the sequence encoding Gly36-Arg37-Arg38 was completely conserved in all of the individuals sequenced. Furthermore, no anomalies were detected in the sequences encoding the exon-intron boundary between intron 2 and exon 3 or between exon 3 and intron 3 in any of the individuals sequenced.
After the sequencing reaction to detect the G to A transition changing the amino acid Val81 to Met81 had been performed for all 201 schizophrenic patients and 67 control subjects, we next genotyped the polymorphism (Val81/Val81, Val81/Met81, and Met81/Met81) in the remaining 108 control subjects by using restriction endonuclease Nla III ( Figure 1 ). Both genotype frequency and allele frequency obtained from the 201 schizophrenic patients and 175 healthy control subjects are summarized in Table 1 . There was no significant difference in either frequency between the 126 control individuals whose parents were born in the Tokai area and the other 49 control individuals whose parents had come from outside the Tokai area (genotype frequency: 2 = 1.38, df = 2, P = 0.50; allele frequency: 2 = 0.56, df = 1, P = 0.45; all 95% confidence intervals of estimated odds ratios contained 1.0). No significant difference in the allele frequency ( 2 = 0.10, df = 1, P = 0.75; odds ratio = 0.91, 95% confidence interval 0.67-1.25) was found between the 201 schizophrenic patients and 175 control subjects. There was also no significant difference in the genotype frequency between two groups ( 2 = 0.30, df = 2, P = 0.86). When the Met81/Met81 genotype is assumed to be the risk exposure, the odds ratio was 1.10 with 95% confidence interval 0.73-1.65. When the Val81/Met81 genotype is assumed to be the risk exposure, the odds ratio was 0.96 with 95% confidence interval 0.65-1.40. When the male and female cases were separately analyzed, no significant differences were detected in these two kinds of frequency (Table 1) , in which all 95% confidence intervals of estimated odds ratios contained 1.0. The genotype frequencies and allele frequencies in schizophrenic patients showed no statistical difference from the control group when analysis was restricted to the 126 control individuals born from the parents who are/were residents of the Tokai area (genotype frequency: 2 = 0.19, df = 2, P = 0.91; allele frequency: 2 = 0.04, df = 1, P = 0.84; all 95% confidence intervals of estimated odds ratios contained 1.0).
In this study, we could not find any mutated sequence except for the previously known polymorphism 12 in exon 3 of human TH gene in 201 Japanese patients suffering from schizophrenia. It is noteworthy that in all of the patients examined there were no mutations in the sequences encoding Gly36-Arg37-Arg38 and other crucial amino acids, Ser31 and Ser40, which are readily phosphorylated to activate human TH activity. 13 In addition, we could not find any anomalous sequence at the exon-intron boundaries to explain the skipping of exon 3 at translation, which occurred in the adrenal medulla of the patient with progressive supranuclear palsy. 14 Ishiguro et al sequenced exon 3 of the human TH gene obtained from 17 cases of Japanese schizophrenic patients and also found no mutations in exon 3 except for the polymorphism Val81/Met81. 15 Collectively, we could not find any evidence from the viewpoint of exon 3 of the human TH gene to rationalize the elevation in the synaptic and/or presynaptic DA concentrations in the schizophrenic brain.
The differences in the catalytic activities of the two forms of the enzyme, the Val81/Val81 form and the Met81/Met81 form, expressed in Escherichia coli were very faint (A Nakashima, unpublished data). The enzyme with a deletion of the first 80 amino acid residues in the N-terminus showed no catalytic activity when expressed in E. coli. 16 In addition, the enzymes with the first 78, 79 or 81 amino acid residues deleted from the N-terminus and the ones in which the first 79 amino acid residues were deleted and contained the transition from Val81 to Gly81, Ser81 or Thr81 revealed no catalytic activities when expressed in E. coli (A Ota, unpublished data). Val81 is known to be located in the stretch of the hydrophobic amino acids beginning from Ala80 in the human TH type 1 enzyme. As the chemical structures of Val and Met are similar, it is reasonable to speculate that from these enzymological data obtained from in vitro experiments, the transition from Val81 to Met81 in human TH enzyme is not critical to modulate its catalytic activity in vivo.
Because the mice whose TH gene was disrupted died of cardiovascular failure in the embryonic days or early in the postnatal days, 17 the fetus possessing the mutated TH enzyme lacking the catalytic activity is expected to die between embryonic days. Mutations in the TH gene outside exon 3 resulting in an amino acid exchange have been almost traced to the neurological disorders L-DOPA-responsive dystonia (Segawa's syndrome) (Gln381Lys 18 and Arg233His 19 ), L-DOPAresponsive parkinsonism (Leu205Pro 20 ) and severe form of TH deficiency (Cys359Phe 21 ) due to the lowered catalytic activities of the mutated enzymes. The facts were already demonstrated 22 that Gln381Lys mutation disturbs the conformation of the active site and that Leu205Pro mutation destabilizes the TH protein. On the contrary, Val468 is located outside the catalytic domain or active site of the TH molecule. 22 In the patients with schizophrenia, the polymorphism Val468Met 15 is the sole report other than Val81Met which resulted in the amino acid change in the TH molecule. The functional difference in TH caused by the Val468Met polymorphism is not known. Because of the low distribution of the mutated allele in Val468Met polymorphism in the patients with schizophrenia and also in the control subjects, 15 it should be required to add the sample size in order to investigate its association with schizophrenia. The intron 1 TCAT tetranucleotide repeat polymorphism 23 in the TH gene has been the focus of research because of the observations that its allelic variation affects catecholamine biosynthesis. 24, 25 However, negative data were reported recently from an analysis using the Japanese population. 15 An A to T transition found in the 5Ј-flanking region showed the allele frequencies which were not significantly different between schizophrenic patients and controls. 15 In this study, we could not find any significant difference in the distribution of the genotypes of Val81/Val81, Val81/Met81, and Met81/Met81 or in that of the frequency of the Val81 allele and Met81 allele between schizophrenic patients and control subjects. This observation is in accordance with the previous reports concerning Japanese schizophrenic patients 15, 26 in that no statistically significant difference could be found in either the distribution of the genotype or The data of schizophrenic patients were compared with those of control subjects by using the 2 -test. 2 -Values, degrees of freedom (df), and P values are listed in the Table. n, the number of individuals or the number of alleles.
allele frequency between the patients and the control subjects. The patients recruited in these two studies were just from Japan's capital area. The comparison of the control subjects between either of these two previous reports and ours did not reveal any difference in the distribution of the genotype and allele frequencies (0.19ϽPϽ0.91). The same results reappeared in the comparison of the control subjects, even if we used control subjects restricted to the residents of two generations in the Tokai area. However, both distributions of the Met81/Met81 genotype and Met81 allele of our schizophrenic patients tended to be higher than those reported by Kunugi et al 26 (P = 0.054 for genotype distribution; P = 0.068 for allele distribution). The distribution of the Met81 allele of our patients also tended to be higher than that reported by Ishiguro et al 15 (P = 0.082). The reasons for such tendencies are still not yet explained fully by the different geographical back-grounds of the patients recruited, because no tendencies in the distributions were detected in the comparison among the three sets of control subjects. It will be necessary to compare the patients by several other aspects, such as their socioeconomical status, which was not controlled in this study. On the other hand, the distribution of the Val81 allele in the Japanese control subjects was much lower than that in Caucasian control subjects. 12 This observation also indicates that the transition from Val81 to Met81 is not critical in determining the in vivo catalytic activity of human TH enzyme.
In conclusion, the search for abnormalities in exon 3 of the human TH gene did not give any rational answer to the elevation in the synaptic and/or presynaptic DA concentrations in the schizophrenic brain. Recently, the blockade of the ␣ 2 adrenoceptor turned out to enhance DA output in the medial prefrontal cor-tex in rat brain, 27 which challenges the basic assumptions underlying the DA hypothesis of schizophrenia. [28] [29] [30] It might be the next task to search for the ␣ 2 adrenoceptor gene from the molecular viewpoint in order to define the etiology of schizophrenia.
Methods

Subjects
The subjects were 201 unrelated Japanese patients with schizophrenia (age 47.8 ± 12.7 years; 98 males (age 47.3 ± 12.5 years) and 103 females (age 48.4 ± 13.0 years)) whose parents were born in the Tokai area (Aichi, Gifu, and Mié Prefectures). All subjects were under medication at hospitals in Nagoya City or in its satellite towns. They were diagnosed based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). One hundred and seventy-five unrelated Japanese healthy controls (age 47.1 ± 11.0 years; 72 males (age 45.7 ± 12.4 years) and 103 females (age 48.2 ± 9.8 years)) were recruited mostly among the medical staffs of the authors' institutions. All control subjects showed good social functioning and had no past psychiatric or neurological disturbances. The study protocol was approved by the ethical committees of the authors' institutions. Written informed consents were obtained from all the individuals recruited in this study.
Polymerase chain reaction (PCR)
Venous blood samples were collected in the tubes containing ethylenediaminetetraacetic acid, and genomic DNA was extracted from peripheral leukocytes according to the manufacturer's instructions (Qiagen, Tokyo, Japan). In order to analyze exon 3 of the TH gene and its exon-intron boundaries, we prepared a sequence of 404 base pairs (bp) composed of 111 bp of intron 2, exon 3 (222 bp), and 71 bp of intron 3 by PCR amplification using the forward primer 5Ј-ATCCC CTGCCTCTGTGTGCCAT-3Ј and the reverse primer 5Ј-TCAGGAACTCAGCCCACACAGC-3Ј. 4 Primer design was based on the report by Ishiguro et al. 15 Genomic DNA (100 ng) was amplified in the following reaction mixture: 50 mM KCl, 10 mM 2-amino-2-hydroxymethyl-1,3-propanediol-HCl (pH 8.3), 1 mM MgCl 2 , 200 M concentration of each deoxynucleotide, 0.3 M concentration of each primer, and 0.5 units of KODPlus-DNA polymerase (Toyobo, Osaka, Japan) in total 25-l reaction solution. After denaturation at 94°C for 2 min, DNA fragments were amplified for 40 cycles by the following steps: 15 s at 94°C, 30 s at 60°C, 30 s at 68°C. Following amplification, the reaction mixture (3 l) was analyzed by 1.5% agarose gel electrophoresis to ensure correct amplification of the DNA fragment.
Direct sequencing of PCR products
Allelic variations in exon 3 were analyzed by direct sequencing of the previous PCR fragments amplified from genomic DNA. Each PCR product (22 l) was purified with a QIAquick PCR purification kit (Qiagen) according to the manufacturer's instructions. The sequencing reaction was performed with the ABI PRISM DNA sequencing kit (BigDye ™ Terminator Cycle Sequencing Ready Reaction; Applied Biosystems, Tokyo, Japan) using AmpliTaq ® DNA polymerase FS. The forward primer used for the reaction was 5Ј-GACTGTGGGACCAGCTGTGGGT-3Ј, which started at 78 bp upstream from the first codon of exon 3. The labeled products were analyzed with an automated capillary sequencer (ABI PRISM 310; PE Biosystems, Tokyo, Japan).
Analysis of polymorphic restriction enzyme sites
In order to analyze the G to A transition in exon 3 which generates the polymorphism from Val81 to Met81, the restriction endonuclease Nla III (New England BioLabs, Tokyo, Japan) was used, because this enzyme recognizes the CATG site encoding Met81 in exon 3. The PCR product (5 l) was digested with 5 U of the enzyme at 37°C for 2 h. The products of each digestion were analyzed by separation on a 2.25% agarose gel electrophoresis, and the bands were visualized by ethidium bromide staining and ultraviolet transillumination.
Statistics
Both genotype frequencies and allele frequencies of polymorphism were evaluated by using 2 -test and Fisher's exact test on 2 × 3 contingency table or 2 × 2 contingency table, respectively, at a significance level of 0.05, two-sided. The sample size was to detect odds ratios of 1.7 or larger with 90% power at the 5% level of significance, assuming about 70% Met81 allele frequency in the Japanese control subjects. 15, 26 When Met81/Met81 genotype is assumed to be the risk exposure in the case-control comparison, the sample size has a power of 90% with the 5% significance level to detect an odds ratio of 2.0 or larger for genotype association, assuming about 40% Met81/Met81 genotype frequency in the Japanese control subjects. 15, 26 When the Val81/Met81 genotype is assumed to be the risk exposure, the sample size has a power of 90% with the 5% significance level to detect an odds ratio of 2.0 or larger assuming about 50% Val81/Met81 genotype frequency in the Japanese control subjects. 15, 26 
